HARMONY reaches milestone capturing data from 45,000 patients with blood cancersMPE, MyelomaJune 25, 2019
Takeda announces discontinuation of the phase 3 clinical trial TOURMALINE-AL1 in AL amyloidosisAccess, AL amyloidosisJune 6, 2019
ASCO 2019 – Lenalidomide reduces risk that smoldering myeloma will progress to myeloma in high risk patientsConferences, MyelomaMay 31, 2019
Lenalidomide and pomalidomide based triplet combination regimens for myeloma patients receives approval from the European CommissionAccess, MyelomaMay 23, 2019
Call to action for Central and Eastern European (CEE) members – join MPE CEE workgroup on accessAccess, MPEMay 6, 2019
Results of MPE members participation in EMA survey on bortezomibMPE, Myeloma, Patient evidenceMay 3, 2019
